A Study Comparing Pathadi Kashaya and Haridradi Kashaya for Managing Type 2 Diabetes in 76 Patients

An Open Randomized Comparative Clinical Study Of Pathadi Kashaya And Haridradi Kashaya In The Management Of Kaphaj Prameha With Special Reference To Type 2 Diabetes Mellitus - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087070

Enrollment

Registered

2025-05-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group of 20 years to 70 years. Sex All genders. Patients with classical signs and symptoms of Kaphaj Prameha Newly diagnosed cases of DM or known case of DM for less than 5 years. Subject who are willing to give written informed consent. BSL Fasting 126 mg per dl to 180 mg per dl And,or post prandial - 140 mg per dl to 200 mg per dl

Exclusion criteria

Exclusion criteria: Patients on insulin therapy. Patient having any Diabetic complications or uncontrolled hyperglycaemia. Patients who are on Immunosuppressant medication. Pregnant women and lactating mother. Known cases of Diabetes Mellitus for more than 5 years. Patients with uncontrolled hypertension Patients with severe kidney or liver dysfunction. Patients with a history of significant cardiovascular events within the last 6 months. Patients who have undergone major surgery within the last 3 months. Patients with any active infections, especially those requiring systemic treatment. Patients with a history of substance abuse like alcohol, drugs within the past year. Patients with severe psychiatric conditions like schizophrenia, bipolar disorder that could impair their ability to comply with the study protocol. Patients with severe gastrointestinal conditions like inflammatory bowel disease, malabsorption syndromes that could affect the absorption of the study medications.

Design outcomes

Primary

Measure	Time frame
Prabhut Mutrata (Excessive Urination) Avil Mutrata (Turbid Urination) Pipasa Adhikya (Excessive Thirst) Ati Kshudha (Excessive Appetite) Kara-Pada Daha (Burning sensation of hands and feet) Shithilangata (Loss of muscle tone) Blood sugar level fasting Blood sugar level post prandialTimepoint: baseline day 15 day 30 day 45 day 60	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactAnaya Ashish Pathrikar

APMS Ayurved Mahavidyalaya, Sion

dhagaigauri@gmail.com9867014440

Outcome results